WASHINGTON, D.C. (Wednesday, March 16, 2011) – The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) announced today that Francis Collins, MD, PhD, Director of the National Institutes of Health, will provide the keynote address at the Partnering for Global Health Forum 2011. The conference will be co-located with the BIO International Convention and will be held June 27, 2011 at the Walter E. Washington Convention Center in Washington, DC.
“Dr. Collins’ vast experience and expertise in cutting-edge biomedical research can enlighten industry leaders striving to deliver much-needed innovative solutions to address the health needs of people in developing nations,” said Jim Greenwood, president and CEO of BIO.
NIH Director Francis Collins, MD, PhD will share his insights on how ground-breaking biotech innovations can serve the health needs of the world’s poorest. Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. He is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project.
“We are thrilled that Dr. Collins will be headlining the Partnering for Global Health Forum. NIH is at the center of supporting the basic science underlying product development for neglected diseases and increasingly involved in translating that science into new drugs, vaccines, and diagnostics,” said Melinda Moree, CEO of BIO Ventures for Global Health.
Partnering for Global Health 2011 will bring together leaders from global health, biopharmaceutical, academic, government, and donor communities and funders supporting global health R&D. Presentations will feature speakers developing and funding technologies and products that will save lives in the developing world.
Non-profit organizations representing the global health community registered for Partnering for Global Health Forum 2011 on June 27th will be eligible to participate in partnering at the Business Forum at the BIO International Convention, June 28th – 30th at no additional cost. Persons eligible for this rate include representatives of funding organizations and non-profit, academic, governmental and non-governmental offices and organizations that are engaged in the fields of public health or neglected disease development. If you are eligible for this rate, please send an email to [email protected].
The BIO Business Forum offers an unparalleled opportunity for large and small biotech companies to gather in one place, at one time to engage in partnering discussions. The ability to schedule up to 80 one-on-one meetings within just a few short days with biotech leaders from around the world enables companies to maximize their ROI for the registration and travel investment for this event. In 2010, the BIO Business Forum hosted more than 17,000 partnering meetings with more than 2,000 companies participating. BIO One-on-One Partnering enables users to search for companies by clinical focus, stage of development, region, or keywords and set up private meetings with company executives.
For the most up-to-date information on the Partnering for Global Health conference, please continue to check the Web site at http://bio.org/pgh/.
Upcoming BIO Events
BIO Intellectual Property Counsels Committee Spring Conference and Committee Meeting
April 13-15, 2011
Seattle, WA
World Congress on Industrial Biotechnology & Bioprocessing
May 8-11, 2011
Toronto, Ontario, Canada
Partnering for Global Health Forum 2011
June 27, 2011
Washington, DC
June 27-30, 2011
Washington, DC
2011 BIO Human Resources Conference
June 26-28, 2011
Washington, DC
The Business Forum at the BIO International Convention
June 28-30, 2011
Washington, DC
BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India
BIO China International Conference
October 12-13, 2011
Shanghai, China
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech Now, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtech Now.
About BVGH
BIO Ventures for Global Health is a non-profit organization whose mission is to save lives by accelerating the development of novel biotechnology-based drugs, vaccines, and diagnostics to address the unmet medical needs of the developing world. The organization spurs biotech industry involvement in global health product development by increasing biotech and global health partnerships, designing and advocating for compelling market-based incentives, and synthesizing and disseminating critical information and quantitative analysis. For more information, please visit www.bvgh.org.
SOURCE
